India · Delayed Price · Currency is INR NSE:STARHEALTH Statistics
Total Valuation
NSE:STARHEALTH has a market cap or net worth of INR 325.98 billion. The enterprise value is 323.35 billion.
| Market Cap | 325.98B |
| Enterprise Value | 323.35B |
Important Dates
The last earnings date was Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:STARHEALTH has 588.40 million shares outstanding. The number of shares has decreased by -0.80% in one year.
| Current Share Class | 588.40M |
| Shares Outstanding | 588.40M |
| Shares Change (YoY) | -0.80% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 3.58% |
| Owned by Institutions (%) | 27.59% |
| Float | 244.38M |
Valuation Ratios
The trailing PE ratio is 38.22 and the forward PE ratio is 20.64. NSE:STARHEALTH's PEG ratio is 0.61.
| PE Ratio | 38.22 |
| Forward PE | 20.64 |
| PS Ratio | 1.69 |
| PB Ratio | 3.12 |
| P/TBV Ratio | 3.15 |
| P/FCF Ratio | 11.98 |
| P/OCF Ratio | 11.59 |
| PEG Ratio | 0.61 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.37, with an EV/FCF ratio of 11.88.
| EV / Earnings | 37.87 |
| EV / Sales | 1.68 |
| EV / EBITDA | 26.37 |
| EV / EBIT | 26.61 |
| EV / FCF | 11.88 |
Financial Position
The company has a current ratio of 21.08, with a Debt / Equity ratio of 0.01.
| Current Ratio | 21.08 |
| Quick Ratio | 8.70 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.03 |
| Interest Coverage | 18.97 |
Financial Efficiency
Return on equity (ROE) is 9.47% and return on invested capital (ROIC) is 8.75%.
| Return on Equity (ROE) | 9.47% |
| Return on Assets (ROA) | 3.33% |
| Return on Invested Capital (ROIC) | 8.75% |
| Return on Capital Employed (ROCE) | 5.01% |
| Weighted Average Cost of Capital (WACC) | 5.42% |
| Revenue Per Employee | 10.38M |
| Profits Per Employee | 459,851 |
| Employee Count | 18,566 |
| Asset Turnover | 0.85 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:STARHEALTH has paid 2.94 billion in taxes.
| Income Tax | 2.94B |
| Effective Tax Rate | 25.63% |
Stock Price Statistics
The stock price has increased by +12.89% in the last 52 weeks. The beta is 0.19, so NSE:STARHEALTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +12.89% |
| 50-Day Moving Average | 548.76 |
| 200-Day Moving Average | 526.99 |
| Relative Strength Index (RSI) | 53.55 |
| Average Volume (20 Days) | 463,977 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:STARHEALTH had revenue of INR 192.81 billion and earned 8.54 billion in profits. Earnings per share was 14.50.
| Revenue | 192.81B |
| Gross Profit | 43.51B |
| Operating Income | 12.15B |
| Pretax Income | 11.48B |
| Net Income | 8.54B |
| EBITDA | 12.26B |
| EBIT | 12.15B |
| Earnings Per Share (EPS) | 14.50 |
Balance Sheet
The company has 3.38 billion in cash and 756.10 million in debt, with a net cash position of 2.63 billion or 4.47 per share.
| Cash & Cash Equivalents | 3.38B |
| Total Debt | 756.10M |
| Net Cash | 2.63B |
| Net Cash Per Share | 4.47 |
| Equity (Book Value) | 104.36B |
| Book Value Per Share | 177.34 |
| Working Capital | 8.58B |
Cash Flow
In the last 12 months, operating cash flow was 28.13 billion and capital expenditures -919.90 million, giving a free cash flow of 27.21 billion.
| Operating Cash Flow | 28.13B |
| Capital Expenditures | -919.90M |
| Depreciation & Amortization | n/a |
| Net Borrowing | -3.97B |
| Free Cash Flow | 27.21B |
| FCF Per Share | 46.24 |
Margins
Gross margin is 22.57%, with operating and profit margins of 6.30% and 4.43%.
| Gross Margin | 22.57% |
| Operating Margin | 6.30% |
| Pretax Margin | 5.95% |
| Profit Margin | 4.43% |
| EBITDA Margin | 6.36% |
| EBIT Margin | 6.30% |
| FCF Margin | 14.11% |
Dividends & Yields
NSE:STARHEALTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.80% |
| Shareholder Yield | 0.80% |
| Earnings Yield | 2.62% |
| FCF Yield | 8.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for NSE:STARHEALTH is 630.59, which is 13.83% higher than the current price. The consensus rating is "Buy".
| Price Target | 630.59 |
| Price Target Difference | 13.83% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (3Y) | 14.92% |
| EPS Growth Forecast (3Y) | 54.73% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |